212 related articles for article (PubMed ID: 38794142)
1. Bee Venom-Loaded Niosomes as Innovative Platforms for Cancer Treatment: Development and Therapeutical Efficacy and Safety Evaluation.
Pinto MB; Pires PC; Calhelha RC; Silva AR; Sousa MJ; Vilas-Boas M; Falcão SI; Veiga F; Makvandi P; Paiva-Santos AC
Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794142
[TBL] [Abstract][Full Text] [Related]
2. Highly in vitro anti-cancer activity of melittin-loaded niosomes on non-small cell lung cancer cells.
Honari P; Shahbazzadeh D; Behdani M; Pooshang Bagheri K
Toxicon; 2024 Apr; 241():107673. PubMed ID: 38432612
[TBL] [Abstract][Full Text] [Related]
3. Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK/ERK pathway.
Abdulmalek S; Mostafa N; Gomaa M; El-Kersh M; Elkady AI; Balbaa M
PLoS One; 2022; 17(8):e0272776. PubMed ID: 35947632
[TBL] [Abstract][Full Text] [Related]
4. Exploring the potential of silymarin-loaded nanovesicles as an effective drug delivery system for cancer therapy: in vivo, in vitro, and in silico experiments.
Hajinezhad MR; Roostaee M; Nikfarjam Z; Rastegar S; Sargazi G; Barani M; Sargazi S
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38630254
[TBL] [Abstract][Full Text] [Related]
5. Bee Venom Components as Therapeutic Tools against Prostate Cancer.
Badawi JK
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34067049
[TBL] [Abstract][Full Text] [Related]
6. Formulation and Characterization of Epalrestat-Loaded Polysorbate 60 Cationic Niosomes for Ocular Delivery.
Kattar A; Quelle-Regaldie A; Sánchez L; Concheiro A; Alvarez-Lorenzo C
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111732
[TBL] [Abstract][Full Text] [Related]
7. Targeting Colorectal Cancer Cells with Niosomes Systems Loaded with Two Anticancer Drugs Models; Comparative In Vitro and Anticancer Studies.
El-Far SW; Abo El-Enin HA; Abdou EM; Nafea OE; Abdelmonem R
Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890115
[TBL] [Abstract][Full Text] [Related]
8. Niosomes-loaded selenium nanoparticles as a new approach for enhanced antibacterial, anti-biofilm, and anticancer activities.
Haddadian A; Robattorki FF; Dibah H; Soheili A; Ghanbarzadeh E; Sartipnia N; Hajrasouliha S; Pasban K; Andalibi R; Ch MH; Azari A; Chitgarzadeh A; Kashtali AB; Mastali F; Noorbazargan H; Mirzaie A
Sci Rep; 2022 Dec; 12(1):21938. PubMed ID: 36536030
[TBL] [Abstract][Full Text] [Related]
9. Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition.
Aziz DE; Abdelbary AA; Elassasy AI
Curr Drug Deliv; 2018; 15(9):1330-1342. PubMed ID: 29921206
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
[TBL] [Abstract][Full Text] [Related]
11. Honeybee Venom Synergistically Enhances the Cytotoxic Effect of CNS Drugs in HT-29 Colon and MCF-7 Breast Cancer Cell Lines.
Duarte D; Falcão SI; El Mehdi I; Vilas-Boas M; Vale N
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335887
[TBL] [Abstract][Full Text] [Related]
12. Microfluidic manufacturing of different niosomes nanoparticles for curcumin encapsulation: Physical characteristics, encapsulation efficacy, and drug release.
Obeid MA; Khadra I; Albaloushi A; Mullin M; Alyamani H; Ferro VA
Beilstein J Nanotechnol; 2019; 10():1826-1832. PubMed ID: 31579065
[TBL] [Abstract][Full Text] [Related]
13. Bee Sting Venom as a Viable Therapy for Breast Cancer: A Review Article.
Bindlish A; Sawal A
Cureus; 2024 Feb; 16(2):e54855. PubMed ID: 38533165
[TBL] [Abstract][Full Text] [Related]
14. Niosome as a promising tool for increasing the effectiveness of anti-inflammatory compounds.
Fadaei MS; Fadaei MR; Kheirieh AE; Rahmanian-Devin P; Dabbaghi MM; Nazari Tavallaei K; Shafaghi A; Hatami H; Baradaran Rahimi V; Nokhodchi A; Askari VR
EXCLI J; 2024; 23():212-263. PubMed ID: 38487088
[TBL] [Abstract][Full Text] [Related]
15. Anticancer Activity of Bee Venom Components against Breast Cancer.
Kwon NY; Sung SH; Sung HK; Park JK
Toxins (Basel); 2022 Jul; 14(7):. PubMed ID: 35878198
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant activity and irritation property of venoms from Apis species.
Somwongin S; Chantawannakul P; Chaiyana W
Toxicon; 2018 Apr; 145():32-39. PubMed ID: 29499244
[TBL] [Abstract][Full Text] [Related]
17. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of bee venom and its major component, melittin, on atopic dermatitis in vivo and in vitro.
An HJ; Kim JY; Kim WH; Gwon MG; Gu HM; Jeon MJ; Han SM; Pak SC; Lee CK; Park IS; Park KK
Br J Pharmacol; 2018 Dec; 175(23):4310-4324. PubMed ID: 30187459
[TBL] [Abstract][Full Text] [Related]
19. To bee or not to bee: The potential efficacy and safety of bee venom acupuncture in humans.
Cherniack EP; Govorushko S
Toxicon; 2018 Nov; 154():74-78. PubMed ID: 30268393
[TBL] [Abstract][Full Text] [Related]
20. Loading of water-insoluble celastrol into niosome hydrogels for improved topical permeation and anti-psoriasis activity.
Meng S; Sun L; Wang L; Lin Z; Liu Z; Xi L; Wang Z; Zheng Y
Colloids Surf B Biointerfaces; 2019 Oct; 182():110352. PubMed ID: 31306831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
